Table 4.
Comparisons of the major adverse pregnancy outcomes in the study groups between the patients on ATDs vs. no ATDs and between the patients using PTU vs. MMI in the subgroup of those on ATDs.
| Outcomes | No ATD n = 158 |
On ATD n = 194 |
p Value | PTU n = 128 |
MMI n = 67 |
p Value |
|---|---|---|---|---|---|---|
| Quantitative data | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| Gestational weeks | 37.7 ± 3.1 | 36.8 ± 3.9 | 0.027 | 37.0 ± 4.2 | 37.2 ± 2.5 | 0.791 |
| Birth weight (grams) | 2943 ± 615 | 2679 ± 792 | 0.001 | 2738 ± 767 | 2728 ± 719 | 0.933 |
| Categorical data | n/N (%) | n/N (%) | n/N (%) | n/N (%) | ||
| Preeclampsia | 16/158 (10.1%) | 15/186 (8.1%) | 0.506 | 11/128 (8.6%) | 4/66 (6.1%) | 0.531 |
| Preterm birth < 37 wk | 24/157 (15.3%) | 45/186 (20.8%) | 0.040 | 26/128 (20.3%) | 15/66(22.7%) | 0.696 |
| Fetal growth restriction | 15/155 (9.7%) | 25/184 (13.6%) | 0.266 | 16/126 (12.7%) | 6/66 (9.1%) | 0.456 |
| Low birth weight | 30/156 (19.2%) | 54/185 (29.2%) | 0.033 | 31/127 (24.4%) | 17/66 (25.8%) | 0.837 |
| Low Apgar | 5/157 (3.2%) | 9/184 (4.9%) | 0.429 | 8/126 (6.3%) | 2/66 (3.0%) | 0.326 |